Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela R Smith

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Pediatric Blood & Cancer|November 16, 2012
Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDSAngela R Smith, Ellen C Christiansen, John E Wagner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2012
Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantationMichael J Burke, Nathan Gossai, John E Wagner, et al.
Bone Marrow Transplantation|January 14, 2021
Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disordersAshish O Gupta, Jaap Jan Boelens, Christen L Ebens, et al.
Pediatric Blood & Cancer|June 7, 2018
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access programNancy A Kernan, Paul G Richardson, Angela R Smith, et al.
British Journal of Haematology|April 27, 2017
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantationPaul G Richardson, Angela R Smith, Brandon M Triplett, et al.
British Journal of Haematology|May 17, 2018
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndromeNancy A Kernan, Stephan Grupp, Angela R Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2017
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND StudyPaul G Richardson, Angela R Smith, Brandon M Triplett, et al.
Pigment Cell & Melanoma Research|July 17, 2018
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cellsJonathan M Eby, Angela R Smith, Timothy P Riley, et al.
The Journal of Allergy and Clinical Immunology|February 7, 2013
Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftmentFederica Cattaneo, Mike Recher, Stefania Masneri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2017
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell TransplantationShalini Shenoy, Emanuele Angelucci, Staci D Arnold, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Pediatric Blood & Cancer|November 16, 2012
Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDSAngela R Smith, Ellen C Christiansen, John E Wagner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2012
Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantationMichael J Burke, Nathan Gossai, John E Wagner, et al.
Bone Marrow Transplantation|January 14, 2021
Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disordersAshish O Gupta, Jaap Jan Boelens, Christen L Ebens, et al.
Pediatric Blood & Cancer|June 7, 2018
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access programNancy A Kernan, Paul G Richardson, Angela R Smith, et al.
British Journal of Haematology|April 27, 2017
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantationPaul G Richardson, Angela R Smith, Brandon M Triplett, et al.
British Journal of Haematology|May 17, 2018
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndromeNancy A Kernan, Stephan Grupp, Angela R Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2017
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND StudyPaul G Richardson, Angela R Smith, Brandon M Triplett, et al.
Pigment Cell & Melanoma Research|July 17, 2018
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cellsJonathan M Eby, Angela R Smith, Timothy P Riley, et al.
The Journal of Allergy and Clinical Immunology|February 7, 2013
Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftmentFederica Cattaneo, Mike Recher, Stefania Masneri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2017
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell TransplantationShalini Shenoy, Emanuele Angelucci, Staci D Arnold, et al.
Pageof 7